Ask the Expert Webinar: Developing Tools to Discover New Therapeutic Agents
Join us as Dr. Roger Ashmus from Simon Fraser University presents his research on developing tools to target the protein GCase (glucocerebrosidase).
Gene mutations in people with Parkinson's cause a deficiency in GCase, which is one of the key risk factors for disease onset. Studies have shown that treating this deficiency could help prevent the progression of Parkinson's in mice models.
Dr. Ashmus uses a combination of organic chemistry, chemical biology, and cell biology in hopes of discovering new therapeutic agents that increase GCase activity.
Register today to reserve a spot for yourself, your household or group! If you will be watching the webinar on the same computer or screen as another person or group, only one registration is required.
||Tuesday, July 16
||10:00am – 11:00am
||Via webinar. Instructions on how to access the presentation will be sent out 24 hours before the webinar's start time.
Please note: In the "Participant Information" section of this webinar registration form, you will be asked for your "Registrant Type". The information collected here will provide a better understanding of the Parkinson's communities in which we serve, as well as improve our advocacy efforts on behalf of those living with Parkinson's disease. If you have any concerns with regard to the collection of this information, please contact us
Parkinson Society British Columbia | 600-890 West Pender Street | Vancouver, BC Canada V6C 1J9